U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07138469) titled 'FRench Elective Oocyte prEservation: a Multicenter Study thrEe Years Later' on June 25.
Brief Summary: Previously reserved for pathological cases, oocyte cryopreservation for non-medical reason also named elective fertility preservation (EFP) is now authorized in France for women aged 29 to 37 following the revision of the bioethics law on August 2nd 2021. Currently, French data related to this new practice are lacking. The aim of this study is to conduct a preliminary assessment 3 years after approval of elective oocyte cryopreservation in France, evaluating the knowledge and perspectives of women undergoing elective fertility pres...